Skip to main content
Failure of first-line IL-17A inhibitor should not deter treatment with second-line IL-17A
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Failure of first-line IL-17A inhibitor should not deter treatment with second-line IL-17A
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriatic Arthritis
1
1
Interleukin Antagonist
0
0.85
Adherence
0
0.69
Monoclonal Antibody
0
0.65
Arthritis
0
0.46
Interleukin
0
0.65
Biologic Therapy
0
0.65
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
1
Orthopaedics
0
0.42
Edit Tags